Position in RPRX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$9,785
+$2,057 QoQ
Shares Held
204
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bogart Wealth, LLC holds $12,250,420 across 40 Biotechnology names. RPRX ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,196 | $12,144,101 | |
| 2 | MRNA |
Moderna, Inc.
|
439 | $22,301 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20 | $15,452 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39 | $12,903 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
204 | $9,785 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
123 | $9,236 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
150 | $7,135 | |
| 8 | GMAB |
Genmab A/S
|
146 | $3,917 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,785 | 204 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $7,728 | 200 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $7,056 | 200 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,206 | 200 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,226 | 200 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,102 | 200 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,658 | 200 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||